Jane Street Group, LLC Arcus Biosciences, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 217,041 shares of RCUS stock, worth $3.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
217,041
Previous 135,848 59.77%
Holding current value
$3.19 Million
Previous $2.07 Million 60.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$13.69 - $18.01 $1.11 Million - $1.46 Million
81,193 Added 59.77%
217,041 $3.32 Million
Q2 2024

Aug 14, 2024
BUY
$14.59 - $18.48 $889,100 - $1.13 Million
60,939 Added 81.35%
135,848 $2.07 Million
Q1 2024

May 15, 2024
SELL
$14.83 - $20.18 $3.81 Million - $5.18 Million
-256,581 Reduced 77.4%
74,909 $1.41 Million
Q4 2023

Feb 14, 2024
BUY
$13.43 - $19.63 $2.96 Million - $4.32 Million
220,191 Added 197.84%
331,490 $6.33 Million
Q3 2023

Nov 14, 2023
SELL
$17.62 - $23.54 $3.12 Million - $4.17 Million
-177,110 Reduced 61.41%
111,299 $2 Million
Q2 2023

Aug 14, 2023
BUY
$16.97 - $22.03 $4.29 Million - $5.57 Million
252,847 Added 711.0%
288,409 $5.86 Million
Q1 2023

May 15, 2023
BUY
$15.96 - $23.15 $154,780 - $224,508
9,698 Added 37.5%
35,562 $648,000
Q4 2022

Feb 14, 2023
SELL
$19.7 - $35.71 $156,949 - $284,501
-7,967 Reduced 23.55%
25,864 $534,000
Q3 2022

Nov 14, 2022
BUY
$23.23 - $30.07 $504,671 - $653,270
21,725 Added 179.46%
33,831 $885,000
Q2 2022

Aug 16, 2022
SELL
$17.23 - $37.73 $219,768 - $481,246
-12,755 Reduced 51.31%
12,106 $307,000
Q1 2022

May 17, 2022
BUY
$28.92 - $41.83 $67,846 - $98,133
2,346 Added 10.42%
24,861 $785,000
Q3 2021

Nov 16, 2021
BUY
$26.93 - $37.68 $606,328 - $848,365
22,515 New
22,515 $786,000
Q2 2021

Aug 16, 2021
SELL
$22.75 - $35.77 $454,931 - $715,292
-19,997 Closed
0 $0
Q1 2021

May 18, 2021
BUY
$26.16 - $41.39 $292,835 - $463,319
11,194 Added 127.16%
19,997 $562,000
Q4 2020

Feb 17, 2021
SELL
$17.0 - $32.36 $103,819 - $197,622
-6,107 Reduced 40.96%
8,803 $228,000
Q3 2020

Nov 17, 2020
SELL
$17.14 - $25.47 $143,033 - $212,547
-8,345 Reduced 35.88%
14,910 $256,000
Q2 2020

Aug 17, 2020
BUY
$13.97 - $36.56 $324,872 - $850,202
23,255 New
23,255 $575,000
Q1 2019

May 16, 2019
SELL
$8.95 - $12.49 $268,115 - $374,162
-29,957 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
$9.74 - $14.5 $291,781 - $434,376
29,957 New
29,957 $323,000

Others Institutions Holding RCUS

# of Institutions
201
Shares Held
51.7M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.06B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email